InvestorsHub Logo
icon url

Nemesis18

08/04/24 8:57 AM

#710688 RE: vator #710682

Why are you arguing my point that it is the Regulator's responsibility to never accept any submitted trial results at face value, irrespective of an external party sign off prior to submission?

Would you buy a car, on the sole basis that the salesman said that it had no defects ?

NWBO is not exempt from the normal Regulatory due diligence processes , which are even more stringent, post covid.

So you all need to get your heads out of your arses, and accept that this rubber-stamping 'special relationship' between NWBO & MHRA is now over.

This Biotech firm now longer wags the Regulator's tail, as NHS England has now grab the lead.

As I said previously, I am unashamedly on the side of vulnerable patients & my Health service, to protect both from commercially incentivised financial exploitation.

If you don't like that, I DO NOT CARE
icon url

learningcurve2020

08/04/24 9:11 AM

#710692 RE: vator #710682

It's never been clear to me how many CRO's they used for the Pll / lll trial. I know they had at least two but unsure if at some point they replaced any??
icon url

attilathehunt

08/04/24 12:59 PM

#710736 RE: vator #710682

He pretends to be looking out for citizens by saving them money...Instead, he is actually wasting citizens taxes (let alone delaying them access to life saving treatment) by his false accusations. He is truly a narcissist.